Convulsions
7
0
0
5
Key Insights
Highlights
Success Rate
83% trial completion
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 52/100
14.3%
1 terminated out of 7 trials
83.3%
-3.2% vs benchmark
43%
3 trials in Phase 3/4
0%
0 of 5 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 5 completed trials
Clinical Trials (7)
Intranasal vs Buccal vs Intramuscular Midazolam for the Home and Emergency Treatment of Acute Seizures
Pharmacokinetics of Understudied Drugs Administered to Children Per Standard of Care
A Study of Cardiac Arrhythmia and ECG Changes in Children With Convulsions at Sohag University Hospital
A Cross-sectional Study to Investigate the Effect of Topiramate on Bone and Mineral Metabolism in Female Participants With Epilepsy
Randomized Trial Comparing 3 Routes of Delivering Lorazepam to Children.
The Utility of Performing Brain CT Scan in Non Trauma Patients at the Pediatric Emergency Unit
Intranasal Lorazepam Versus Intramuscular Paraldehyde in Paediatric Convulsions